No Prescription |
 |
 | ||
|
Estraderm TTS 100 Generic Estradiol |
|
| ||
No Prescription » Prescription Drugs 7 » Estraderm TTS 100 Generic Estradiol Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Estraderm estradiol transdermal system is designed to release estradiol through a rate-limiting membrane continuously upon application to intact skin. Estraderm« (estradiol transdermal system) is indicated in: 1. Treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy topical vaginal products should be considered. 3. Treatment of hypoestrogenism due to hypogonadism castration or primary ovarian failure. 4. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis therapy should only be considered for women at significant risks of osteoporosis and non-estrogen medications should be carefully considered. The mainstays for decreasing the risk of postmenopausal osteoporosis are weight-bearing exercise adequate calcium and vitamin D intake and when indicated pharmacologic therapy. Postmenopausal women require an average of 1500 mg/day of elemental calcium. Therefore when not contraindicated calcium supplementation may be helpful for women with suboptimal dietary intake. Vitamin D supplementation of 400-800 IU/day may also be required to ensure adequate daily intake in postmenopausal women. Buy Estraderm TTS 100 Generic Estradiol and other Prescription Drugs 7 products online at Medstore. 3829
About Estraderm TTS 100 Generic Estradiol: Product Type: Prescription Drugs 7 Estraderm TTS 100 ( Generic Estradiol ) Estraderm TTS 100 (Generic Estradiol) Generic Estradiol 8mg 16 ( 2 x 8 ) Patches Generic Estradiol Estraderm TTS 100
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
